Abbott Labs (ABT) Tops Q3 EPS by 3c; Raises FY14 EPS Midpoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq on track for record closing highs as focus turns to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Mylan (MYL), Abbott (ABT) Enter Amended Agreement; Will be Accretive to Mylan
October 22, 2014 7:26 AM EDTOn October 21, 2014, Mylan Inc. (Nasdaq: MYL), a Pennsylvania corporation, New Moon B.V., a private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) organized under the laws of the Netherlands, Moon of PA Inc., a Pennsylvania corporation, and Abbott Laboratories (NYSE: ABT), an Illinois corporation, entered into an amendment in connection with pre-closing actions required to be taken pursuant to the Business... More



